Kanae Kudo

1.1k total citations
30 papers, 962 citations indexed

About

Kanae Kudo is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kanae Kudo has authored 30 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kanae Kudo's work include Wnt/β-catenin signaling in development and cancer (4 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer Cells and Metastasis (3 papers). Kanae Kudo is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (4 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer Cells and Metastasis (3 papers). Kanae Kudo collaborates with scholars based in Japan and United States. Kanae Kudo's co-authors include Kazuto Nishio, Yoshihiko Fujita, Tokuzo Arao, Hiroyasu Kaneda, Keiichi Aomatsu, Daisuke Tamura, Kaoru Tanaka, Kunio Matsumoto, Yasuhide Yamada and Kazuko Sakai and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Kanae Kudo

30 papers receiving 957 citations

Peers

Countries citing papers authored by Kanae Kudo

Since Specialization

Citations

This map shows the geographic impact of Kanae Kudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanae Kudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanae Kudo more than expected).

Fields of papers citing papers by Kanae Kudo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanae Kudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanae Kudo. The network helps show where Kanae Kudo may publish in the future.

Co-authorship network of co-authors of Kanae Kudo

This figure shows the co-authorship network connecting the top 25 collaborators of Kanae Kudo. A scholar is included among the top collaborators of Kanae Kudo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanae Kudo. Kanae Kudo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Tight Junction Protein ZO-1 and TWIST Expression on Postoperative Survival of Patients with Hepatocellular Carcinoma 2016 ·Digestive Diseases ·Tomoyuki Nagai, Tokuzo Arao, Kazuto Nishio, Kunio Matsumoto, Satoru Hagiwara, Toshiharu Sakurai, Yasunori Minami, Hiroshi Ida, Kazuomi Ueshima, Naoshi Nishida, Kazuko Sakai, Nagahiro Saijo, Kanae Kudo, Hiroyasu Kaneda, Daisuke Tamura, Keiichi Aomatsu, Hideharu Kimura, Yoshihiko Fujita, Seiji Haji, Masatoshi Kudo	17
2	The Changes of c-Fos Expression by Motor Cortex Stimulation in the Deafferentation Pain Model 2014 ·Neurologia medico-chirurgica ·Kanae Kudo, Toshio Takahashi, Shigeharu Suzuki	9
3	SRPX2 is a Novel Chondroitin Sulfate Proteoglycan that is Overexpressed in Gastrointestinal Cancer 2012 ·Annals of Oncology ·Kéiichi Tanaka, (unknown), Daisuke Tamura, Keiichi Aomatsu, Kazuyuki Furuta, Kunio Matsumoto, Hiroyasu Kaneda, Kanae Kudo, (unknown), (unknown), Kazuyoshi Yanagihara, Yoshiki Yamada, Isamu Okamoto, (unknown), (unknown)	2
4	SRPX2 Is a Novel Chondroitin Sulfate Proteoglycan That Is Overexpressed in Gastrointestinal Cancer 2012 ·PLoS ONE ·Kaoru Tanaka, Tokuzo Arao, Daisuke Tamura, Keiichi Aomatsu, Kazuyuki Furuta, Kunio Matsumoto, Hiroyasu Kaneda, Kanae Kudo, Yoshihiko Fujita, Hideharu Kimura, Kazuyoshi Yanagihara, Yasuhide Yamada, Isamu Okamoto, Kazuhiko Nakagawa, Kazuto Nishio	37
5	Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma 2011 ·Molecular Cancer Therapeutics ·Tomoyuki Nagai, Tokuzo Arao, Kazuyuki Furuta, Kazuko Sakai, Kanae Kudo, Hiroyasu Kaneda, Daisuke Tamura, Keiichi Aomatsu, Hideharu Kimura, Yoshihiko Fujita, Kazuko Matsumoto, Nagahiro Saijo, Masatoshi Kudo, Kazuto Nishio	101
6	Integrated analysis of whole genome exon array and array‐comparative genomic hybridization in gastric and colorectal cancer cells 2011 ·Cancer Science ·Kazuyuki Furuta, Tokuzo Arao, Kazuko Sakai, Hideharu Kimura, Tomoyuki Nagai, Daisuke Tamura, Keiichi Aomatsu, Kanae Kudo, Hiroyasu Kaneda, Yoshihiko Fujita, Kazuko Matsumoto, Yasuhide Yamada, Kazuyoshi Yanagihara, Masaru Sekijima, Kazuto Nishio	17
7	Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer 2011 ·British Journal of Cancer ·Hiroyasu Kaneda, Tokuzo Arao, Kunio Matsumoto, Marco A. De Velasco, Daisuke Tamura, Keiichi Aomatsu, Kanae Kudo, Kazuko Sakai, Tomoyuki Nagai, Yoshihiko Fujita, Kaoru Tanaka, Kazuyoshi Yanagihara, Yasuhide Yamada, Isamu Okamoto, Kazuhiko Nakagawa, Kazuto Nishio	88
8	Acquired drug resistance to vascular endothelial growth factor receptor 2 tyrosine kinase inhibitor in human vascular endothelial cells. 2011 ·PubMed ·Tokuzo Arao, Kunio Matsumoto, Kazuyuki Furuta, Kanae Kudo, Hiroyasu Kaneda, Tomoyuki Nagai, Kazuko Sakai, Yoshihiko Fujita, Daisuke Tamura, Keiichi Aomatsu, Fumiaki Koizumi, Kazuto Nishio	27
9	Aza-derivatives of resveratrol are potent macrophage migration inhibitory factor inhibitors 2011 ·Investigational New Drugs ·Yoshihiko Fujita, Rafiqul Islam, Kazuko Sakai, Hiroyasu Kaneda, Kanae Kudo, Daisuke Tamura, Keiichi Aomatsu, Tomoyuki Nagai, (unknown), Kazuko Matsumoto, Marco A. De Velasco, Tokuzo Arao, Tadashi Okawara, Kazuto Nishio	18
10	A case of anaplastic clear-cell ependymoma presenting with high erythropoietin concentration and 1p/19q deletions 2011 ·Brain Tumor Pathology ·Kenichiro Asano, Kanae Kudo, Fumiaki Mori, Hiroki Ohkuma, Koichi Wakabayashi	2
11	FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth 2010 ·Cancer Research ·Hiroyasu Kaneda, Tokuzo Arao, Kaoru Tanaka, Daisuke Tamura, Keiichi Aomatsu, Kanae Kudo, Kazuko Sakai, Marco A. De Velasco, Kunio Matsumoto, Yoshihiko Fujita, Yasuhide Yamada, Junji Tsurutani, Isamu Okamoto, Kazuhiko Nakagawa, Kazuto Nishio	157
12	Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker In Vivo 2010 ·Clinical Cancer Research ·Kanae Kudo, Tokuzo Arao, Kaoru Tanaka, Tomoyuki Nagai, Kazuyuki Furuta, Kazuko Sakai, Hiroyasu Kaneda, Kazuko Matsumoto, Daisuke Tamura, Keiichi Aomatsu, Marco A. De Velasco, Yoshihiko Fujita, Nagahiro Saijo, Masatoshi Kudo, Kazuto Nishio	31
13	Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition 2010 ·Cancer Science ·Daisuke Tamura, Tokuzo Arao, Kaoru Tanaka, Hiroyasu Kaneda, Kunio Matsumoto, Kanae Kudo, Keiichi Aomatsu, Yoshihiko Fujita, Takashi Watanabe, Nagahiro Saijo, Yoshikazu Kotani, Yoshihiro Nishimura, Kazuto Nishio	48
14	Usefulness of the Post-Vascular Phase of Contrast-Enhanced Ultrasonography with Sonazoid in the Evaluation of Gross Types of Hepatocellular Carcinoma 2010 ·Oncology ·Kinuyo Hatanaka, Hobyung Chung, Masatoshi Kudo, Seiji Haji, Yasunori Minami, Kiyoshi Maekawa, (unknown), Tomoyuki Nagai, Masahiro Takita, Kanae Kudo, Taisuke Ueda, Chie Tatsumi, Satoshi Kitai, Emi Ishikawa, Norihisa Yada, Tatsuo Inoue, Satoru Hagiwara, Kazuomi Ueshima	28
15	Abstract 3893: Overexpression of FOXQ1 is important factor in tumorigenicity and tumor growth 2010 ·Cancer Research ·Hiroyasu Kaneda, Tokuzo Arao, Kaoru Tanaka, Daisuke Tamura, Keiichi Aomatsu, Kanae Kudo, Kazuko Sakai, Marco A. De Velasco, Kazuko Matsumoto, Yoshihiko Fujita, Yasuhide Yamada, Junji Tsurutani, Isamu Okamoto, Kazuhiko Nakagawa, Kazuto Nishio, Tomoyuki Nagai, Kazuyuki Furuta	1
16	mTOR Signal and Hypoxia-Inducible Factor-1α Regulate CD133 Expression in Cancer Cells 2009 ·Cancer Research ·Kunio Matsumoto, Tokuzo Arao, Kaoru Tanaka, Hiroyasu Kaneda, Kanae Kudo, Yoshihiko Fujita, Daisuke Tamura, Keiichi Aomatsu, Tomohide Tamura, Yasuhide Yamada, Nagahiro Saijo, Kazuto Nishio	114
17	Epidermal growth factor receptor lacking C‐terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor 2009 ·Cancer Science ·(unknown), Tokuzo Arao, Hideyuki Yokote, Kazuko Matsumoto, Kanae Kudo, Kaoru Tanaka, Hiroyasu Kaneda, Yoshihiko Fujita, Fumiaki Ito, Kazuto Nishio	13
18	EGFR mutation up-regulates EGR1 expression through the ERK pathway. 2009 ·PubMed ·(unknown), Tokuzo Arao, Hideyuki Yokote, Kazuko Matsumoto, Kanae Kudo, Kaoru Tanaka, Hiroyasu Kaneda, Yoshihiko Fujita, Fumiaki Ito, Kazuto Nishio	26
19	SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion 2008 ·International Journal of Cancer ·Kaoru Tanaka, Tokuzo Arao, (unknown), Kunio Matsumoto, Hiroyasu Kaneda, Kanae Kudo, Yoshihiko Fujita, Hideyuki Yokote, Kazuyoshi Yanagihara, Yasuhide Yamada, Isamu Okamoto, Kazuhiko Nakagawa, Kazuto Nishio	82
20	Spontaneously Ruptured Craniopharyngioma Cyst Without Meningitic Symptoms. Two Case Reports. 2003 ·Neurologia medico-chirurgica ·Toshio Takahashi, Kanae Kudo, Satoshi Ito, Shigeharu Suzuki	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact